Skip to content
Clinical Trials – home
Therapeutic area

Infections and infestations – page 47

  • 686 clinical trials
  • 263 recruiting
  • 279 conditions
  • 27 countries

Conditions in this area

279 conditions with trials, the busiest first

Clinical trials in Infections and infestations

686 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

686 clinical trials

Infection

Not recruiting

Title: Study of gentamicin, vancomycin and cefazolin antibiotics to prevent infections in women having breast reconstruction surgery with implants

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cefazolin Sodium
  • Sponsor:Rigshospitalet

Syphilis

Not recruiting

Study of Linezolid and Benzathine Benzylpenicillin for Treating Patients with Early Syphilis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid
  • Sponsor:Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia

HIV infection

Not recruiting

Study of Injectable Cabotegravir Compared to Oral Emtricitabine/Tenofovir for HIV Prevention in Men Who Have Sex with Men

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cabotegravir
  • Sponsor:Inserm

COVID-19

Not recruiting

Study of Baricitinib in Children Aged 1 to 17 Hospitalized with COVID-19

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

Study on the Effects of GSL-01-001 for Patients with Irritable Bowel Syndrome (IBS) Type D

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Cannabidiol
  • Sponsor:Cannabibs Sp. z o.o.

Sepsis+1

Not recruiting

Study on Epirubicin and Sodium Chloride for Patients with Sepsis or Septic Shock in Intensive Care Units

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Friedrich-Schiller-Universitaet Jena

Study of Leniolisib for Children Aged 4 to 11 with Activated PI3K Delta Syndrome

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Leniolisib Phosphate
  • Sponsor:Pharming Technologies B.V.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Landiolol Hydrochloride
  • Sponsor:Assistance Publique Hopitaux De Paris

Chronic fatigue syndrome+1

Not recruiting

Study of Pregabalin Treatment and Rehabilitation for Chronic Fatigue in Post-COVID Syndrome Patients

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Pregabalin
  • Sponsor:Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher

Cystic fibrosis

Not recruiting

Study on Thymalfasin for Adults with Cystic Fibrosis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Thymalfasin
  • Sponsor:Sciclone Pharmaceuticals International (SG) Pte. Ltd.

Sepsis

Not recruiting

Study of hydrocortisone and fludrocortisone combination versus placebo in adults with sepsis in intensive care unit to determine corticosteroid response

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Betamethasone
  • Sponsor:Assistance Publique Hopitaux De Paris

Chronic hepatitis B

Not recruiting

Study of tenofovir disoproxil versus placebo for children aged 2-12 years with chronic hepatitis B infection

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Tenofovir Disoproxil
  • Sponsor:Gilead Sciences Inc.

Substances studied in this area

The therapies tested most often in Infections and infestations trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.